Our Resources | Association for Accessible Medicines

New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework

Video

May 13, 2020 | Erica Klinger

COVID Response: Sweta Modha at Apotex

Preview of The New York Times article: William Haddad, Crusader for Generic Drugs, Dies at 91

May 13, 2020 | Bob Billings

Thank You, Bill Haddad

Video

May 9, 2020 | Erica Klinger

COVID Response: AAM Board Chair Alok Sonig

AAM Blueprint for U.S. Pharmaceutical Supply Chain - header

Apr 30, 2020 | Jonathan Kimball

AAM’s Plan for Strengthening the Generic Drug Supply Chain

Supply Chain Shipping - Medical Supplies

Apr 30, 2020 | Rachel Schwartz

Pharmaceutical Shipping Costs Spike in Response to Global COVID-19 Pandemic

AAM Blueprint Supply Chain Header

Apr 30, 2020 | Erica Klinger

A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

AAM Blueprint Supply Chain Header

Apr 30, 2020 | Rachel Schwartz

AAM Releases Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

Video

Apr 20, 2020 | Erica Klinger

COVID-19 Response: Anthony Maffia at Sandoz

Video

Apr 16, 2020 | Erica Klinger

COVID-19 Response: Roby Epting at Sandoz

Apr 10, 2020 | Erica Klinger

Generics and Biosimilars Industry Supply Chain & Response to COVID-19

Mar 31, 2020 | Erica Klinger

AAM Letter to President on "Buy American" Requirements

Protective Mask - COVID-19

Mar 30, 2020 | Jeff Francer

COVID-19: This Week’s Initiatives From the Generic and Biosimilars Industry